DSM-Firmenich Weighs Animal Unit Sale on Weak Vitamin Market
This article is for subscribers only.
DSM-Firmenich AG is considering the sale of its animal, nutrition and health unit in a bid to reduce its exposure to a deteriorating vitamin market. The shares jumped.
The firm will consider all separation options for the unit as it explores a different ownership structure, the group said in a Thursday statement. It plans to be in a position to carve out the business in 2025.